IONIS PHARMACEUT reported $2.13M in Interest Expense on Debt for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alnylam Pharmaceuticals ALNY:US $ 42.61M 247K
Biocryst Pharmaceuticals BCRX:US $ 24.02M 0.18M
Biomarin Pharmaceutical BMRN:US $ 3.86M 0.05M
Esperion Therapeutics ESPR:US $ 14.27M 204K
Halozyme Therapeutics HALO:US $ 3.1M 1.34M
Intercept Pharmaceuticals ICPT:US $ 6.67M 0M
Moderna Inc MRNA:US 5M 1000K
Nektar Therapeutics NKTR:US $ 7.23M 0.3M
Neurocrine Biosciences NBIX:US $ 2.2M 0.4M
Novartis NOVN:VX 202M 1000K
Omeros OMER:US $ 4.93M 14K
Pfizer PFE:US $ 293M 29M
Ptc Therapeutics PTCT:US $ 22.28M 1.34M
Regeneron Pharmaceuticals REGN:US $ 13.1M 0.5M
Sarepta Therapeutics SRPT:US $ 16.03M 0.23M
Vertex Pharmaceuticals VRTX:US $ 14.6M 0.3M